Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Swisse Plus Cholesterol Capsules is a premium dietary supplement developed in collaboration with the Department of Nutrition at Sun Yat-sen University, specifically formulated to manage dyslipidemia. The product's primary active ingredients are plant sterols (phytosterols), which are structurally similar to cholesterol. These sterols work by competitively inhibiting the absorption of both dietary and biliary cholesterol within the small intestine. By displacing cholesterol from mixed micelles and potentially interacting with the Niemann-Pick C1-like 1 (NPC1L1) transporter protein, the capsules effectively reduce the amount of cholesterol that enters the bloodstream. This mechanism leads to a decrease in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels, supporting overall cardiovascular health and lipid management in adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Swisse Plus Cholesterol Capsules.